knowledge -WSS

knowledge

author：entertainment 2025-09-28 05:39:27 - browse：56

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Digital health funding stays low as a new reality sets in

focus

WSS

One Duchenne patient's bittersweet hope for new treatment

Superbugs, antibiotic resistance get scrutiny in congress

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

hotspot

knowledge

Wikipedia

Heart attack and stroke risk calculators need revising

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Grail's uphill battle for Medicare to cover its cancer screening test

Wildfire smoke exposes gaps in outdoor worker protections

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Duchenne breakthrough therapy leaves behind pioneering families

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Drug repurposing or repositioning? The language matters

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

hotspot

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Biden declares emergency in flood

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

Sickle cell gene therapy cures need to be accessible in Africa

focus

Wikipedia

focus

knowledge